National Guideline Clearinghouse | Ranibizumab for treating choroidal neovascularisation associated with pathological myopia.

full-text ►

National Guideline Clearinghouse | Ranibizumab for treating choroidal neovascularisation associated with pathological myopia.



National Institute for Health and Care Excellence (NICE)

March 24, 2014

Guideline Title

Ranibizumab for treating choroidal neovascularisation associated with pathological myopia.

Bibliographic Source(s)

National Institute for Health and Care Excellence (NICE). Ranibizumab for treating choroidal neovascularisation associated with pathological myopia. London (UK): National Institute for Health and Care Excellence (NICE); 2013 Nov. 41 p. (Technology appraisal guidance; no. 298).

Guideline Status

This is the current release of the guideline.